Literature DB >> 4370023

Filter assay for 1alpha, 25-dihydroxyvitamin D3. Utilization of the hormone's target tissue chromatin receptor.

P F Brumbaugh, D H Haussler, K M Bursac, M R Haussler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4370023     DOI: 10.1021/bi00717a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  15 in total

1.  The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.

Authors:  R A Kaplan; M R Haussler; L J Deftos; H Bone; C Y Pak
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

2.  Osteomalacia due to 1alpha,25-dihydroxycholecalciferol deficiency. Association with a giant cell tumor of bone.

Authors:  M K Drezner; M N Feinglos
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

3.  Current status of vitamin D metabolism.

Authors:  A Fairney
Journal:  Proc R Soc Med       Date:  1977-02

4.  Competitive protein-binding assay for 24,25-dihydroxycholecalciferol.

Authors:  C M Taylor; P De Silva; S E Hughes
Journal:  Calcif Tissue Res       Date:  1977-05

5.  1,25-Dihydroxyvitamin D3: mode of action in intestine and parathyroid glands, assay in humans and isolation of its glycoside from Solanum malacoxylon.

Authors:  M R Haussler; M R Hughes; T A McCain; J E Zerwekh; P F Brumbaugh; W Jubiz; R H Wasserman
Journal:  Calcif Tissue Res       Date:  1977-05

6.  1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation.

Authors:  D D Bikle; M K Nemanic; E Gee; P Elias
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

7.  Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.

Authors:  M R Hughes; D J Baylink; P G Jones; M R Haussler
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 8.  Vitamin D and metabolites measurement by tandem mass spectrometry.

Authors:  Johannes M W van den Ouweland; Michael Vogeser; Silvia Bächer
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

9.  Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.

Authors:  M K Drezner; K W Lyles; M R Haussler; J M Harrelson
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

10.  Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol.

Authors:  P R Skolnik; B Jahn; M Z Wang; T R Rota; M S Hirsch; S M Krane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.